Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
Abstract Background Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Although marker genes associated with CRC have been identified previously, only a few have fulfilled the therapeutic demand. Therefore, based on differentially expressed genes (DEGs), this study aime...
Main Authors: | Di Wang, Junye Liufu, Qiyuan Yang, Shengqun Dai, Jiaqi Wang, Biao Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13062-022-00342-w |
Similar Items
-
Unveiling Prognostic RNA Biomarkers through a Multi-Cohort Study in Colorectal Cancer
by: Zehwan Kim, et al.
Published: (2024-03-01) -
Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis
by: Zeenat Mirza, et al.
Published: (2023-06-01) -
Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
by: Lin Pang, et al.
Published: (2023-03-01) -
Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA
by: Lu Cao, et al.
Published: (2023-03-01) -
Identifying Potential Effective Diagnostic and Prognostic Biomarkers in Sepsis by Bioinformatics Analysis and Validation
by: Huang X, et al.
Published: (2022-07-01)